Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $62,650.00. Following the transaction, the chief financial officer now owns 85,767 shares of the company’s stock, valued at $614,091.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Teladoc Health Price Performance
Shares of NYSE:TDOC opened at $7.44 on Thursday. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of -5.28 and a beta of 0.90. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $23.18. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $8.34 and a 200 day simple moving average of $11.55.
Teladoc Health (NYSE:TDOC – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.08. The business had revenue of $642.44 million during the quarter, compared to analysts’ expectations of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -0.71 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Teladoc Health
Analysts Set New Price Targets
TDOC has been the subject of several analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $10.00 price objective on shares of Teladoc Health in a research report on Tuesday, August 20th. Piper Sandler decreased their price objective on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research note on Friday, August 2nd. Bank of America decreased their price target on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a research note on Tuesday, May 14th. Finally, TD Cowen dropped their price objective on Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $12.44.
Read Our Latest Research Report on TDOC
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
- Five stocks we like better than Teladoc Health
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- How Starbucks and Airbnb Fit Buffett’s Winning Stock Strategy
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Earnings Per Share Calculator: How to Calculate EPS
- Introduction to Fibonacci Retracement Levels
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.